0LO4.L
Ventas, Inc. [0LO4.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0LO4.L Stock Summary
Top 10 Correlated ETFs
0LO4.L
Top 10 Correlated Stocks
0LO4.L
In the News
0LO4.L Financial details
Company Rating
Neutral
Market Cap
17.19B
Income
-40.97M
Revenue
4.5B
Book val./share
23.54
Cash/share
1.4
Dividend
1.8
Dividend %
3.74%
Employees
486
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
3942.33
Forward P/E
-
PEG
-2153.37
P/S
4.45
P/B
1.94
P/C
30.76
P/FCF
22.01
Quick Ratio
0.56
Current Ratio
0.71
Debt / Equity
1.42
LT Debt / Equity
1.24
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
-
EPS this Y
-23.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.04%
Revenue Q/Q
1.27%
EPS Q/Q
27.78%
-
-
-
-
SMA20
-2.33%
SMA50
-8.7%
SMA100
-6.67%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
0.02%
Gross Margin
43%
Oper. Margin
13%
Profit Margin
-
Payout
14965%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
39.4-50.75
52W High
-13.88%
52W Low
+10.41%
RSI
47
Rel Volume
0.12
Avg Volume
4.01K
Volume
492
Perf Week
-0.02%
Perf Month
-0.85%
Perf Quarter
2.01%
Perf Half Y
-1.01%
-
-
-
-
Beta
1.288
-
-
Volatility
0.33%, 0.6%
Prev Close
1.51%
Price
43.06
Change
1.41%
0LO4.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 10.58 | 10.17 | 10 | 11.06 | 11.19 | |
| Net income per share | 1.18 | 1.18 | 0.13 | -0.13 | -0.1 | |
| Operating cash flow per share | 3.93 | 3.88 | 2.73 | 3.08 | 2.97 | |
| Free cash flow per share | 3.5 | 3.49 | 2.24 | 2.48 | 2.33 | |
| Cash per share | 0.4 | 1.21 | 0.51 | 0.46 | 1.4 | |
| Book value per share | 28.54 | 27.27 | 28.36 | 27.19 | 23.61 | |
| Tangible book value per share | 25.54 | 24.47 | 25.39 | 24.43 | 21.91 | |
| Share holders equity per share | 28.54 | 27.27 | 28.36 | 27.19 | 23.61 | |
| Interest debt per share | 34.48 | 31.86 | 32.6 | 34.21 | 35.03 | |
| Market cap | 21.09B | 17.82B | 19.63B | 16.75B | 20.13B | |
| Enterprise value | 33.35B | 29.47B | 31.66B | 29.16B | 33.33B | |
| P/E ratio | 48.7 | 40.57 | 400.53 | -353.09 | -491.31 | |
| Price to sales ratio | 5.45 | 4.69 | 5.13 | 4.06 | 4.48 | |
| POCF ratio | 14.66 | 12.29 | 18.8 | 14.59 | 16.85 | |
| PFCF ratio | 16.46 | 13.69 | 22.86 | 18.09 | 21.53 | |
| P/B Ratio | 2.02 | 1.75 | 1.81 | 1.65 | 2.12 | |
| PTB ratio | 2.02 | 1.75 | 1.81 | 1.65 | 2.12 | |
| EV to sales | 8.61 | 7.76 | 8.27 | 7.06 | 7.41 | |
| Enterprise value over EBITDA | 17.43 | 17.33 | 20.01 | 17.96 | 18.21 | |
| EV to operating cash flow | 23.19 | 20.32 | 30.32 | 25.39 | 27.91 | |
| EV to free cash flow | 26.03 | 22.64 | 36.87 | 31.48 | 35.65 | |
| Earnings yield | 0.02 | 0.02 | 0 | 0 | 0 | |
| Free cash flow yield | 0.06 | 0.07 | 0.04 | 0.06 | 0.05 | |
| Debt to equity | 1.16 | 1.17 | 1.11 | 1.21 | 1.42 | |
| Debt to assets | 0.49 | 0.5 | 0.49 | 0.51 | 0.55 | |
| Net debt to EBITDA | 6.41 | 6.85 | 7.6 | 7.64 | 7.21 | |
| Current ratio | 0.52 | 0.62 | 0.38 | 0.33 | 0 | |
| Interest coverage | 2.17 | 0 | 1.34 | 1.12 | 1.13 | |
| Income quality | 3.32 | 3.3 | 21.3 | -24.21 | -29.15 | |
| Dividend Yield | 0.05 | 0.05 | 0.03 | 0.04 | 0.04 | |
| Payout ratio | 2.67 | 2.12 | 14.02 | -15.18 | -17.66 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.04 | |
| Capex to operating cash flow | -0.11 | -0.1 | -0.18 | -0.19 | -0.22 | |
| Capex to revenue | -0.04 | -0.04 | -0.05 | -0.05 | -0.06 | |
| Capex to depreciation | -0.17 | -0.16 | -0.19 | -0.2 | -0.22 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham number | 27.57 | 26.86 | 9.04 | 8.82 | 7.36 | |
| ROIC | 0.05 | 0.04 | 0.02 | 0.02 | 0.03 | |
| Return on tangible assets | 0.02 | 0.02 | 0 | 0 | 0 | |
| Graham Net | -36.94 | -34.38 | -34.39 | -35.78 | -35.26 | |
| Working capital | -525.5M | -416.04M | -680.24M | -853.45M | -1.26B | |
| Tangible asset value | 9.35B | 9.14B | 9.72B | 9.12B | 8.8B | |
| Net current asset value | -13.3B | -12.73B | -13.07B | -13.24B | -14.88B | |
| Invested capital | 1.16 | 1.17 | 1.11 | 1.21 | 1.42 | |
| Average receivables | 264.43M | 224.27M | 173.29M | 182.21M | 190.82M | |
| Average payables | 925.99M | 965.71M | 966.23M | 955.42M | 469.72M | |
| Average inventory | 0 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Days sales outstanding | 26.28 | 16.32 | 16.87 | 16.58 | 15.75 | |
| Days payables outstanding | 130.09 | 121.14 | 115.62 | 101.66 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 13.89 | 22.36 | 21.64 | 22.02 | 23.17 | |
| Payables turnover | 2.81 | 3.01 | 3.16 | 3.59 | 0 | |
| Inventory turnover | 0 | 2.9B | 0 | 3.37B | 0 | |
| ROE | 0.04 | 0.04 | 0 | 0 | 0 | |
| Capex per share | -0.43 | -0.4 | -0.48 | -0.59 | -0.65 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.63 | 2.69 | 2.76 | 2.85 | 2.89 | |
| Net income per share | -0.11 | 0.04 | 0.26 | -0.18 | -0.23 | |
| Operating cash flow per share | 0.67 | 0.61 | 0.78 | 0.9 | 0.69 | |
| Free cash flow per share | 0.5 | 0.5 | 0.65 | 0.74 | 0.45 | |
| Cash per share | 0.43 | 0.49 | 0.53 | 1.22 | 1.4 | |
| Book value per share | 25.4 | 24.99 | 24.89 | 24.37 | 23.54 | |
| Tangible book value per share | 22.83 | 22.48 | 22.85 | 21.73 | 21.84 | |
| Share holders equity per share | 25.4 | 24.99 | 24.89 | 24.37 | 23.54 | |
| Interest debt per share | 31.08 | 31.18 | 33.72 | 33.61 | 33.81 | |
| Market cap | 17.93B | 17.04B | 18.8B | 16.94B | 20.19B | |
| Enterprise value | 30.34B | 29.47B | 32.25B | 30.13B | 33.39B | |
| P/E ratio | -99.58 | 243.24 | 45.44 | -59.56 | -55.58 | |
| Price to sales ratio | 17.06 | 15.82 | 17 | 14.74 | 17.34 | |
| POCF ratio | 67.1 | 70.19 | 60.3 | 46.96 | 72.34 | |
| PFCF ratio | 89.71 | 85.54 | 72.57 | 57.11 | 112.14 | |
| P/B Ratio | 1.77 | 1.7 | 1.89 | 1.73 | 2.13 | |
| PTB ratio | 1.77 | 1.7 | 1.89 | 1.73 | 2.13 | |
| EV to sales | 28.86 | 27.36 | 29.15 | 26.2 | 28.68 | |
| Enterprise value over EBITDA | 80.22 | 69.65 | 67.5 | 67.06 | 69.44 | |
| EV to operating cash flow | 113.53 | 121.36 | 103.42 | 83.49 | 119.66 | |
| EV to free cash flow | 151.79 | 147.91 | 124.45 | 101.53 | 185.48 | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Debt to equity | 1.21 | 1.23 | 1.34 | 1.36 | 1.42 | |
| Debt to assets | 0.51 | 0.51 | 0.53 | 0.54 | 0.55 | |
| Net debt to EBITDA | 32.81 | 29.37 | 28.14 | 29.34 | 27.46 | |
| Current ratio | 0.33 | 0.42 | 0.41 | 0.71 | 0 | |
| Interest coverage | -5.66 | 1.14 | 1.26 | 1 | -5.09 | |
| Income quality | -5.94 | 13.86 | 3.01 | -5.07 | -3.07 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | -4 | 10.36 | 1.74 | -2.54 | -2 | |
| Sales general and administrative to revenue | 0.03 | 0.04 | 0.03 | 0.03 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.06 | 0.06 | 0.05 | 0.06 | 0.04 | |
| Capex to operating cash flow | -0.25 | -0.18 | -0.17 | -0.18 | -0.35 | |
| Capex to revenue | -0.06 | -0.04 | -0.05 | -0.06 | -0.09 | |
| Capex to depreciation | -0.06 | -0.16 | -0.18 | -0.22 | -0.08 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Graham number | 8.02 | 4.96 | 12.03 | 9.84 | 10.93 | |
| ROIC | -0.03 | 0.01 | 0.01 | 0.01 | -0.03 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -33.43 | -33.33 | -36 | -35.23 | -35.16 | |
| Working capital | -853.45M | -586.28M | -637.15M | -326.55M | -1.26B | |
| Tangible asset value | 9.12B | 8.99B | 9.15B | 8.75B | 8.8B | |
| Net current asset value | -13.24B | -13.24B | -14.32B | -14.03B | -14.88B | |
| Invested capital | 1.21 | 1.23 | 1.34 | 1.36 | 1.42 | |
| Average receivables | 184.89M | 189.09M | 192.11M | 192.86M | 193.12M | |
| Average payables | 953.78M | 927.86M | 943.41M | 986.32M | 501.05M | |
| Average inventory | 0.5 | 0.5 | 0.5 | 0.5 | 0 | |
| Days sales outstanding | 16.05 | 15.93 | 15.75 | 15.04 | 15 | |
| Days payables outstanding | 50.28 | 93.37 | 95.13 | 94.38 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 5.61 | 5.65 | 5.72 | 5.98 | 6 | |
| Payables turnover | 1.79 | 0.96 | 0.95 | 0.95 | 0 | |
| Inventory turnover | 1.68B | 0 | 918.24M | 0 | 0 | |
| ROE | 0 | 0 | 0.01 | -0.01 | -0.01 | |
| Capex per share | -0.17 | -0.11 | -0.13 | -0.16 | -0.25 |
0LO4.L Frequently Asked Questions
What is Ventas, Inc. stock symbol ?
Ventas, Inc. is a US stock , located in Chicago of Il and trading under the symbol 0LO4.L
What is Ventas, Inc. stock quote today ?
Ventas, Inc. stock price is $43.06 today.
Is Ventas, Inc. stock public?
Yes, Ventas, Inc. is a publicly traded company.
Company Profile
- Volume Average 4.01K
- Market Capitalization 17.19B
- Employee 486
- CEO Ms. Debra A. Cafaro
- Headquarters Chicago,IL,US
- IPO Date 2018-01-29
-
Website
https://www.ventasreit.com 
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
